NASDAQ

BioNTech SE - American Depositary Shares (BNTX)

541 Thanks from members

BioNTech SE shares surged over 20% amid optimism surrounding its late-stage oncology pipeline, Moderna's melanoma trial success, and EU vaccine wins, despite declining COVID-19 revenues, widened losses, and lowered full-year financial guidance.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →